IP Verse

Miltenyi competitive analysis

Loading summary...

Latest oppositions filed by Miltenyi

Explore patent oppositions filed by Miltenyi against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3696277
Quantitative Dna-Based Imaging And Super-Resolution ImagingPRESIDENT AND FELLOWS OF HARVARD COLLEGESep 8, 2023
EP3247808
Point-Of-Care And/Or Portable Platform For Gene TherapyFRED HUTCHINSON CANCER RESEARCH CENTERFeb 1, 2022
EP3237442
CellAUTOLUSApr 8, 2020
EP3214091
Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJul 2, 2019
EP2734538
Method Of Reversibly Staining A Target CellIBAFeb 1, 2019
EP2364480
Substance Monitoring And Control In Human Or Animal BodiesCAMBRIDGE ENTERPRISEDec 7, 2018
EP2782997
Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical ApplicationsGENETHONOct 9, 2018
EP2651978
Use Of An Antibody Directed Against A Membrane ProteinLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESFeb 9, 2018

Latest patents of Miltenyi opposed by its competitors

Explore Miltenyi's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3134512
Jan 2, 2019Method For Automated Generation Of Genetically Modified T Cells3
EP3025719
Sep 26, 2018Combination Immunotherapy Of Antigen-Recognizing Receptors And Hematopoietic Cells For The Treatment Of Diseases1

Latest publications and patents of Miltenyi New

Explore the latest publications and patents granted to Miltenyi, showcasing their recent innovations and technological advancements.

Last updated on: Oct 20, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Miltenyi

EP3134512
Jan 2, 2019Method For Automated Generation Of Genetically Modified T CellsRevoked
EP3025719
Sep 26, 2018Combination Immunotherapy Of Antigen-Recognizing Receptors And Hematopoietic Cells For The Treatment Of DiseasesRevoked
EP2227271
Jan 24, 2018Sample Processing System And MethodsNo Opposition Filed Within Time Limit

Latest PTAB cases involving Miltenyi

Discover the latest PTAB cases involving Miltenyi, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 26, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Miltenyi

IPR2023-00760Mar 22, 2023MILTENYI BIOMEDICINEFRED HUTCHINSON CANCER CENTERInstitution Denied
IPR2022-00852Apr 12, 2022MILTENYI BIOMEDICINETHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIATerminated-Settled
IPR2022-00853Apr 12, 2022MILTENYI BIOMEDICINENOVARTIS PHARMAInstitution Denied
IPR2022-00855Apr 12, 2022MILTENYI BIOMEDICINETHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIATerminated-Settled

Peer Comparison New

IP litigation analysis comparing Miltenyi with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MILTENYI BIOTEC64 - -
AUTOLUS - 3 - -
D YOUNG29 - - -
FRED HUTCHINSON CANCER RESEARCH CENTER - 13 - -